CLINICAL_TRIALS
trial_result
· 2016-04-05
Clinical Trial Update: Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial comparing Fasiglifam (TAK-875) to placebo in adults with type 2 diabetes; results were posted in April 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2016-04-05